Charles River director sells 75K shares at $225
Charles River Laboratories director James C. Foster reported an open-market sale of 75,000 shares of common stock at $225.00 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Charles River Laboratories director James C. Foster reported an open-market sale of 75,000 shares of common stock at $225.00 per share. The sale was executed pursuant to a Rule 10b5-1 Trading Plan adopted on March 6, 2026. After the sale, he holds 31,596 shares directly and additional indirect holdings through various trusts and GRATs.
Insider Trade Summary 10b5-1
Net Seller: 75,000 shares
Net Sell
6 txns
Insider
FOSTER JAMES C
Role
Director
Sold
75,000 shs ($16.88M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 75,000 | $225.00 | $16.88M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 31,596 shares (Direct);
Common Stock — 10,780 shares (Indirect, 2025 GRAT);
Common Stock — 20,000 shares (Indirect, 2026 GRAT);
Common Stock — 155,611 shares (Indirect, By Trust);
Common Stock — 10,000 shares (Indirect, By Trust Held By Spouse);
Common Stock — 5,423 shares (Indirect, 2024 GRAT)
Footnotes (1)
- F1. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted by the reporting person on March 6, 2026.
Key Figures
Shares sold: 75,000 shares
Sale price: $225.00 per share
Approximate transaction value: $16.9M
+4 more
7 metrics
Shares sold
75,000 shares
Open-market sale of common stock on June 29, 2026
Sale price
$225.00 per share
Price received for each share sold
Approximate transaction value
$16.9M
75,000 shares sold at $225.00 per share
Direct holdings after sale
31,596 shares
Common stock held directly following the transaction
Indirect 2024 GRAT holdings
5,423 shares
Common stock held indirectly via 2024 GRAT
Indirect trust holdings
155,611 shares
Common stock held indirectly by trust
Indirect 2026 GRAT holdings
20,000 shares
Common stock held indirectly via 2026 GRAT
Key Terms
Rule 10b5-1 Trading Plan, GRAT, open-market sale, indirect ownership
4 terms
Rule 10b5-1 Trading Plan regulatory
"This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted by the reporting person on March 6, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
GRAT financial
"nature_of_ownership: "2024 GRAT" and "2025 GRAT" and "2026 GRAT""
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
"direct_or_indirect: "I", ownership_type: "indirect" for several trust and GRAT holdings"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CRL report for James C. Foster?
CRL reported that director James C. Foster sold 75,000 shares of common stock at $225.00 per share. After this open-market sale, he retained 31,596 shares directly, plus additional indirect holdings through several trusts and grantor retained annuity trusts (GRATs).
Was the CRL insider sale made under a Rule 10b5-1 plan?
Yes. The filing states the 75,000-share sale occurred pursuant to a Rule 10b5-1 Trading Plan. The plan was adopted by the reporting person on March 6, 2026, indicating the trade was pre-arranged rather than timed discretionarily around short-term market movements.
What indirect CRL holdings are reported for James C. Foster?
The filing shows indirect ownership of 5,423 shares in a 2024 GRAT, 10,780 shares in a 2025 GRAT, 20,000 shares in a 2026 GRAT, 10,000 shares in a trust held by his spouse, and 155,611 shares held by another trust, all in Charles River common stock.
Does this CRL Form 4 include any option exercises or derivative transactions?
No. The derivative section is empty, and the transaction summary shows zero derivative exercises or derivative transactions. The only reported activity is a non-derivative open-market sale of 75,000 shares of Charles River common stock, along with several holding entries for indirect share positions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates